Spider Phobia Opposite Action Treatment Study

Status Terminated

Clinical Trial Summary

This study tests the effectiveness of exposure therapy for fear of spiders as enhanced by the use of antagonistic or opposite actions during treatment. The goal of the study is to compare the efficacy threat-relevant opposite actions and threat-irrelevant opposite actions in extinguishing fear.

Clinical Trial Description

This study tests whether exposure therapy for fear of spiders can be enhanced with the use of opposite actions, which are actions opposite to fear-related action tendencies. The investigators will test two sub-types of opposite actions (a) threat-relevant opposite actions, which are actions antagonistic to specific threats associated with spider phobia, and (b) threat-irrelevant opposite actions, which are actions antagonistic to the fear response, but unrelated to specific threats associated with spider phobia. This exposure therapy enhanced with opposite actions will be compared with two control groups: standard exposure therapy and non-specific anxiety treatment (biofeedback relaxation training). Individuals between the ages of 18-65 with elevated fear of spiders are randomly assigned to one of four treatment conditions (1) biofeedback relaxation training, (2) standard exposure therapy, (3) exposure therapy with threat-relevant opposite actions, and (4) exposure therapy with threat-irrelevant opposite actions. All participants undergo an online prescreen and a face-to-face screening assessment to determine eligibility and baseline (pre-treatment) symptom severity. Participants additionally complete assessments directly after treatment (post-treatment), and approximately two weeks after treatment (follow-up). The pre-treatment assessment occurs on the same day as treatment, the post-treatment assessment occurs during the treatment visit as soon as the treatment procedure is complete, and the follow-up assessment occurs within a window of 14-21 days after the completion of treatment. Participants complete two behavioral approach tests (in the treatment context and in the generalization context) at pre-treatment, post-treatment, and follow-up. Participants complete a battery of self-report questionnaires at pre-treatment and follow-up. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02905279
Study type	Interventional
Source	University of Texas at Austin
Contact
Status	Terminated
Phase	N/A
Start date	June 1, 2016
Completion date	December 12, 2017

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT04594525` - Maternal Telemental Health Interventions in Response to Covid-19*	N/A
Completed	`NCT02306356` - Internet-delivered Treatment for Children With Anxiety Disorders in a Rural Area; an Open Trial in a Clinical Setting	N/A
Completed	`NCT03233113` - The Effects of Safety Seeking Behaviors During Exposure Therapy for Adults With Spider Phobia	N/A
Completed	`NCT04504773` - Using Immersive Virtual Reality to Treat Pediatric Anxiety	N/A
Completed	`NCT05300061` - Values Interventions for Increasing Engagement With What is Feared in Individuals With Specific Phobias	N/A
Completed	`NCT03208400` - Virtual Reality Exposure in Spider Phobia	N/A
Completed	`NCT03688373` - Facing Fears in Big or Smalls Steps?	N/A
Completed	`NCT03688360` - Facing Fears In-session or Out-session?	N/A
Recruiting	`NCT02305537` - Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment	N/A
Terminated	`NCT03764644` - Web-based Attention Bias Modification Treatment for Childhood Anxiety Disorders	N/A
Terminated	`NCT01979263` - Attention Bias Modification Treatment for Anxious Youth	N/A
Not yet recruiting	`NCT02972112` - Ultrashort Cognitive Behavioral Intervention for Tokophobia- A Prospective Randomized Single Blinded Controlled Trial	N/A
Completed	`NCT02554838` - How to Act on the Mobility Restriction Linked to Senior's Phobia of Falling	N/A
Completed	`NCT01491880` - Treatment Study for Rural Latino Youth With Anxiety	Phase 1/Phase 2
Completed	`NCT01947647` - Transdiagnostic Psychotherapy for Veterans With Mood and Anxiety Disorders	N/A
Recruiting	`NCT04563390` - Effectiveness of a Projection-based Augmented Reality Exposure System in Treating Cockroach Phobia.	N/A
Completed	`NCT05284435` - Internet-Based, Parent-Led Cognitive-Behavioral Therapy for Anxiety in Youth With ASD	N/A
Completed	`NCT03105024` - Self-efficacy Enhancement and Exposure Therapy	N/A
Completed	`NCT01923896` - D-cycloserine and Treatment of Feeding Disorders	Phase 1/Phase 2
Recruiting	`NCT03917550` - RECOVERY: A Transdiagnostic Intervention for Anxiety and Depression	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.